Clinical trial
Efficacy and Safety Study of QVA149 in COPD Patients
NCT02487446
Study timeline
Study start (actual)2015-07-28Date precision: day
Registry last updated2017-12-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Chronic Obstructive Pulmonary Diseaseunresolved
Interventions
Sponsors & collaborators
Novartis Pharmaceuticalslead sponsor
Mapped research locations
ColumbusOhio, United States2MinneapolisMinnesota, United States2PensacolaFlorida, United States2New YorkNew York, United States1PhiladelphiaPennsylvania, United States1MiamiFlorida, United States1CincinnatiOhio, United States1PortlandOregon, United States1Salt Lake CityUtah, United States1CharlotteNorth Carolina, United States1TucsonArizona, United States1Winston-SalemNorth Carolina, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02487446 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.